- Fri17May2024
1.00pm - 4.30pmLondon
Format: This is a half-day course held in the afternoon only. It is a live, in-person event with the option of attending virtually.Description: In this course, Elaine provides an overview of bowel cancer biology and genetics and the science behind various treatment approaches. Treatments explained include monoclonal antibodies targeting EGFR and small molecules such as B Raf inhibitors. She describes the reason for giving checkpoint inhibitors to selected patients and mentions other treatment approaches in trials.
Audience: This content is ideal for research nurses, clinical nurse specialists, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with bowel cancer.
To book, contact: conferenceteam@rmh.nhs.uk
Cost: £80 for in-person or virtual attendance
- Fri17May2024
9.00am - 12.30pmLondon
Format: This is a half-day course held in the morning only. It is a live, in-person event with the option of attending virtually.Description: In this course, Elaine provides an overview of the biology and genetics of oesophageal cancer, stomach cancer, small bowel cancer, pancreatic cancer, liver cancer and cancers of the biliary system.
She also explains the science behind various treatment approaches for these diseases, including relevant targeted therapies and immunotherapies as well as approaches in trials.Audience: This content is ideal for research nurses, clinical nurse specialists, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with upper GI cancers.
To book, contact: conferenceteam@rmh.nhs.uk
Cost: £80 for in-person or virtual attendance
- Tue04Jun2024
All dayCentral London
Format: This study day will be held in central London from approx. 10am - 4.30pm. You can also ask to attend virtually.Description: This course is designed specifically for those new to cancer or those wishing to refresh their knowledge. In the morning, Elaine looks at the mechanisms of action of chemotherapy, hormone therapy, targeted therapy and immunotherapy. In the afternoon, she describes what biomarkers are, where they’re found, how they’re detected, and what they’re used for.
Audience: This course is ideal for nurses who are new to caring for cancer patients or who wish to refresh and expand their knowledge. This course is also suitable for anyone involved in cancer research and trials.
Cost: £150 to attend in-person, £140 to attend virtually
To book, contact: conferenceteam@rmh.nhs.ukBiomarkers programme_1 day_12July2024
- Tue10Sep2024
1.00pm - 4.30pmLondon
Format: This is a half-day course held in the afternoon only. It is a live, in-person event with the option of attending virtually.Description: In this course, Elaine provides an overview of the biology and genetics of ovarian, endometrial, cervical, vulval and vaginal cancers. She will also explain the science behind various treatment approaches for these diseases, including relevant targeted therapies and immunotherapies and approaches in trials. Because of their importance, Elaine will pay particular attention to the use of PARP inhibitors to treat women with ovarian cancer.
Audience: This content is ideal for research nurses, clinical nurse specialists, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of women with gynaecological cancers.
To book, contact: conferenceteam@rmh.nhs.uk
Cost: £80 for in-person or virtual attendance (£150 to attend this course and the morning on melanoma on the same day)
- Tue10Sep2024
9am - 12.30pmLondon
Format: This is a half-day course held in the morning only. It is a live, in-person event with the option of attending virtually.Description: This morning, Elaine provides an up-to-date overview of the science behind targeted treatments and immunotherapies for people diagnosed with melanoma. She begins with the gene mutations that cause melanoma and describes the biology of this disease and its relationship with the immune system. She then describes various treatment approaches, such as B-Raf and MEK inhibitors and immunotherapy with checkpoint inhibitors.
Audience: This content is ideal for research nurses, clinical nurse specialists, pharmacists and clinical trials coordinators. It may also be of interest to other healthcare professionals involved in the diagnosis and treatment of people with melanoma.
To book, contact: conferenceteam@rmh.nhs.uk
Cost: £80 for in-person or virtual attendance (£150 to attend this course and the gynae course in the afternoon)
- Tue03Dec2024
9.15am - 4pmCentral London - in person
Description: Throughout this in-person study day, Elaine will guide you through the scientific concepts that underpin many of the most prescribed targeted treatments & immunotherapies for people with solid tumours. There is also an option to attend virtually.Treatments include a wide variety of antibody-based therapies targeting cell surface proteins and small molecules targeting various kinases and other proteins involved in cell communication. Elaine will discuss progress to date with checkpoint inhibitors and describe other forms of immunotherapy such as treatment vaccines, CAR T cells and TCR-modified T cells. She will also talk about the promise and limitations of antibody-drug conjugates such as trastuzumab deruxtecan.
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine's other courses
Cost: £150 to attend in person, or £140 to attend virtually
To book, contact: conferenceteam@rmh.nhs.uk
Solid tumours FULL DAY Programme_December2024